|Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition|
M Kriege, CTM Brekelmans, C Boetes, PE Besnard, HM Zonderland, ...
New England Journal of Medicine 351 (5), 427-437, 2004
|Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer|
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
|Rapid detection of BRCA1 mutations by the protein truncation test|
FBL Hogervorst, RS Cornelis, M Bout, M van Vliet, JC Oosterwijk, R Olmer, ...
Nature genetics 10 (2), 208, 1995
|Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility|
MM De Jong, IM Nolte, GJ Te Meerman, WTA Van der Graaf, ...
Journal of medical genetics 39 (4), 225-242, 2002
|Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer|
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
|Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk|
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS Genet 9 (3), e1003212, 2013
|Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study|
EM Hoogerwaard, E Bakker, PF Ippel, JC Oosterwijk, DF Majoor-Krakauer, ...
The Lancet 353 (9170), 2116-2119, 1999
|Identification of six new susceptibility loci for invasive epithelial ovarian cancer|
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
|Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study|
EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ...
European urology 66 (3), 489-499, 2014
|A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families|
T Peelen, M Van Vliet, A Petrij-Bosch, R Mieremet, C Szabo, ...
American journal of human genetics 60 (5), 1041, 1997
|Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age|
DM van der Kolk, GH de Bock, BK Leegte, M Schaapveld, MJE Mourits, ...
Breast cancer research and treatment 124 (3), 643-651, 2010
|Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy|
EM Hoogerwaard, PA Van der Wouw, AAM Wilde, E Bakker, PF Ippel, ...
Neuromuscular Disorders 9 (5), 347-351, 1999
|Normal phenotype in two brothers with a full FMR1 mutation|
HJM Smeets, APT Smits, CE Verheij, JPG Theelen, R Willemsen, I Burgt, ...
Human molecular genetics 4 (11), 2103-2108, 1995
|BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.|
AJ Rijnsburger, IM Obdeijn, R Kaas, MM Tilanus-Linthorst, C Boetes, ...
|Inheritance of most X‐linked traits is not dominant or recessive, just X‐linked|
WB Dobyns, A Filauro, BN Tomson, AS Chan, AW Ho, NT Ting, ...
American journal of medical genetics Part A 129 (2), 136-143, 2004
|Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer|
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
|Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?|
NM Van Der Velde, MJE Mourits, HJG Arts, J de Vries, BK Leegte, ...
International Journal of Cancer 124 (4), 919-923, 2009
|Georg Schmorl on trophoblasts in the maternal circulation|
O Lapaire, W Holzgreve, JC Oosterwijk, R Brinkhaus, DW Bianchi
Placenta 28 (1), 1-5, 2007
|Novel types of mutation responsible for the dermatosparactic type of Ehlers–Danlos syndrome (type VIIC) and common polymorphisms in the ADAMTS2 gene|
A Colige, L Nuytinck, I Hausser, AJ Van Essen, M Thiry, C Herens, ...
Journal of Investigative Dermatology 123 (4), 656-663, 2004
|Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.|
MS Van Roosmalen, PFM Stalmeier, CG Verhoef, J Hoekstra-Weebers, ...